Radiation therapy in the elderly

Cancer Journal

Volumn 11, Issue 6, 2005, Pages 495-505

  Mell, Loren K ^a,b   Mundt, Arno J ^a,b  

^a University of Chicago ^*

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Elderly; Outcomes; Radiation therapy; Toxicity

Indexed keywords

AMIFOSTINE; DOCETAXEL; TAMOXIFEN;

AGING; BRACHYTHERAPY; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ELDERLY CARE; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVIEW; SOCIAL ASPECT; STEREOTAXIC SURGERY; STOMATITIS;

AGED; ANIMALS; BRACHYTHERAPY; HUMANS; MIDDLE AGED; NEOPLASMS; RADIOSURGERY; RADIOTHERAPY; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 30744456029     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200511000-00009     Document Type: Review

References (140)

1. National Cancer Institute. Radiation therapy for cancer: questions and answers. Cancer Facts [Web site]. 08/25/04. Available at: http://cis.nci.nih. gov/fact/7_1.htm. Accessed May 26, 2005.
2. National Cancer Institute. United States Cancer Statistics: 2001 Incidence and Mortality. Atlanta, GA: Centers for Disease Prevention and Control; 2004
3. Mor V, Masterson-Allen S, Goldberg RJ et al. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc 1985;33:585-589.
4. Samet J, Hunt WC, Key C et al. Choice of cancer therapy varies with age of patient. JAMA 1986;255:3385-3390.
5. Goodwin JS, Samet JM, Hunt WC. Determinants of survival in older cancer patients. J Natl Cancer Inst 1996;88:1031-1038.
6. Lash TL, Silliman RA, Guadagnoli E et al. The effect of less than definitive care on breast carcinoma recurrence and mortality. Cancer 2000;89:1739-1747.
7. Yancik R, Wesley MN, Ries LA et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001;285:885-892.
8. O'Connell JB, Maggard MA, Ko CY. Cancer-directed surgery for localized disease: decreased use in the elderly. Ann Surg Oncol 2004;11:962-969.
9. Silliman RA, Guadagnoli E, Weitberg AB et al. Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Gerontol 1989;44:M46-M50.
10. Rodrigues NA, Dillon D, Carter D et al. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women. Cancer 2003;97:1393-1403.
11. Teeter SM, Holmes FF, McFarlane MJ. Lung carcinoma in the elderly population. Influence of histology on the inverse relationship of stage to age. Cancer 1987;60:1331-1336.
12. Holmes FF. Clinical evidence for change in tumor aggressiveness with age. In: Balducci L, Lyman GH, Ershler WB, eds. Geriatric Oncology. Philadelphia, PA: JB Lippincott Company; 1992:86-91.
13. Goodwin JS, Hunt WC, Samet JM. Determinants of cancer therapy in elderly patients. Cancer 1993;72:594-601.
14. Goodwin JS, Hunt WC, Samet JM. A population-based study of functional status and social support networks of elderly patients newly diagnosed with cancer. Arch Intern Med 1991;151:366-370.
15. Mor V, Allen S, Malin M. The psychosocial impact of cancer on older versus younger patients and their families. Cancer 1994;74:2118-2127.
16. Steinfeld AD, Diamond JJ, Hanks GE et al. Patient age as a factor in radiotherapy. Data from the Patterns of Care Study. J Am Geriatr Soc 1989;37:335-338.
17. Berkman B, Rohan B, Sampson S. Myths and biases related to cancer in the elderly. Cancer 1994;74:2004-2008.
18. Newcomb PA, Carbone PP. Cancer treatment and age: patient perspectives. J Natl Cancer Inst 1993;85:1580-1584.
19. Wasil T, Lichtman SM, Gupta V et al. Radiation therapy in cancer patients 80 years of age and older. Am J Clin Oncol 2000;23:526-530.
20. Olmi P, Ausili-Cefaro G. Radiotherapy in the elderly: a multicentric prospective study on 2060 patients referred to 37 Italian radiation therapy centers. Rays 1997;22:53-56.
21. Huguenin P, Glanzmann C, Lutolf UM. Acute toxicity of curative radiotherapy in elderly patients. Strahlenther Onkol 1996;172:658-663.
22. Given CW, Given BA, Stommel M. The impact of age, treatment, and symptoms on the physical and mental health of cancer patients. A longitudinal perspective. Cancer 1994;74:2128-2138.
23. Zachariah B, Balducci L, Venkattaramanabalaji GV et al. Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys 1997;39:1125-1129.
24. Nozaki M, Murakami Y, Furuta M et al. Radiation therapy for cancer in elderly patients over 80 years of age. Radiat Med 1998;16:491-494.
25. Oguchi M, Ikeda H, Watanabe T et al. Experiences of 23 patients > or = 90 years of age treated with radiation therapy. Int J Radiat Oncol Biol Phys 1998;41:407-413.
26. Mitsuhashi N, Hayakawa K, Yamakawa M et al. Cancer in patients aged 90 years or older: radiation therapy. Radiology 1999;211:829-833.
27. Rockwell S, Hughes CS, Kennedy KA. Effect of host age on microenvironmental heterogeneity and efficacy of combined modality therapy in solid tumors. Int J Radiat Oncol Biol Phys 1991;20:259-263.
28. Rudat V, Dietz A, Conradt C et al. In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer. Radiother Oncol 1997;43:181-188.
29. Little JB, Nove J, Strong LC et al. Survival of human diploid skin fibroblasts from normal individuals after X-irradiation. Int J Radiat Biol 1988;54:899-910.
30. Baeyens A, Van Den Broecke R, Makar A et al. Chromosomal radiosensitivity in breast cancer patients: influence of age of onset of the disease. Oncol Rep 2005;13:347-353.
31. Hopewell JW, Young CM. The effect of field size on the reaction of pig skin to single doses of X rays. Br J Radiol 1982;55:356-361.
32. Masuda K, Matsuura K, Withers HR et al. Age dependency of response of the mouse skin to single and multifractionated gamma irradiation. Radiother Oncol 1986;7:147-153.
33. Landuyt W, van der Schueren E. Effect of age on the radiation-induced repopulation in mouse lip mucosa. Strahlenther Onkol 1991;167:41-45.
34. Rosen EM, Goldberg ID, Myrick KV et al. Radiation survival of vascular smooth muscle cells as a function of age. Int J Radiat Biol Relat Stud Phys Chem Med 1985;48:71-79.
35. Sargent EV, Burns FJ. Repair of radiation-induced DNA damage in rat epidermis as a function of age. Radiat Res 1985;102:176-181.
36. Moulder JE, Fish BL. Age dependence of radiation nephropathy in the rat. Radiat Res 1997;147:349-353.
37. Hamlet R, Hopewell JW. The differential response of the skin in young and old rats to a combination of X-rays and 'wet' or 'dry' hyperthermia. Int J Radiat Biol Relat Stud Phys Chem Med 1986;50:853-859.
38. Hamilton E, Franks LM. Cell proliferation and ageing in mouse colon. II. Late effects of repeated x-irradiation in young and old mice. Eur J Cancer 1980;16:663-669.
39. Olofsen-van Acht MJ, van Hooije CM, van den Aardweg GJ et al. Effect of age on radiation-induced early changes of rat rectum. A histological time sequence. Radiother Oncol 2001;59:71-79.
40. van den Aardweg GJ, Olofsen-van Acht MJ, van Hooije CM et al. Radiation-induced rectal complications are not influenced by age: a dose fractionation study in the rat. Radiat Res 2003;159:642-650.
41. Crosfill ML, Lindop PJ, Rotblat J. Variation of sensitivity to ionizing radiation with age. Nature 1959;183:1729-1730.
42. Hursh JB, Casarett GW. The lethal effect of acute x-irradiation on rats as a function of age. Br J Radiol 1956;29:169-171.
43. Lamproglou I, Baillet F, Boisserie G et al. The influence of age on radiation-induced cognitive deficit: experimental studies on brain irradiation of 30 Gy in 10 sessions and 12 hours in the Wistar rat at 1 1/2, 4 and 18 months age. Can J Physiol Pharmacol 2002;80:679-685.
44. Mell LK, Mundt AJ. Radiation therapy in the older cancer patient. In: Multidisciplinary treatment and management of cancer in the elderly. Muss HB, Johnson KA, Hunter CP (eds). Marcel Dekker, 2005.
45. Lusinchi A, Bourhis J, Wibault P et al. Radiation therapy for head and neck cancers in the elderly. Int J Radiat Oncol Biol Phys 1990;18:819-823.
46. Chin R, Fisher RJ, Smee RI et al. Oropharyngeal cancer in the elderly. Int J Radiat Oncol Biol Phys 1995;32:1007-1016.
47. Pignon T, Horiot JC, van den Bogaert W et al. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer 1996;32A:2075-2081.
48. Allal AS, Maire D, Becker M et al. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly. Cancer 2000;88:648-652.
49. Kodaira T, Fuwa N, Furutani K et al. Phase I trial of weekly docetaxel and concurrent radiotherapy for head and neck cancer in elderly patients or patients with complications. Jpn J Clin Oncol 2005;35:173-176.
50. Gava A, Bertossi L, Zorat PL et al. Radiotherapy in the elderly with lung carcinoma: the experience of the Italian "Geriatric Radiation Oncology Group." Rays 1997;22:61-65.
51. Jeremic B, Shibamoto Y, Milicic B et al. A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 1999;44:343-348.
52. Pignon T, Gregor A, Schaake-Konig C et al. Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol 1998;46:239-248.
53. Kusumoto S, Koga K, Tsukino H et al. Comparison of survival of patients with lung cancer between elderly (greater than or equal to 70) and younger (70 greater than) age groups. Jpn J Clin Oncol 1986;16:319-323.
54. Koga K, Kusumoto S, Watanabe K et al. Age factor relevant to the development of radiation pneumonitis in radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 1988;14:367-371.
55. Pergolizzi S, Santacaterina A, Renzis CD et al. Older people with non small cell lung cancer in clinical stage IIIA and co-morbid conditions. Is curative irradiation feasible? Final results of a prospective study. Lung Cancer 2002;37:201-206.
56. Hayakawa K, Mitsuhashi N, Katano S et al. High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer 2001;32:81-88.
57. Schild SE, Stella PJ, Geyer SM et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 2003;21:3201-3206.
58. Antonadou D, Throuvalas N, Petridis A et al. Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2003;57:402-408.
59. Komaki R, Lee JS, Milas L et al. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 2004;58:1369-1377.
60. Koukourakis M, Kyrias G, Kakolyris S et al. Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study. J Clin Oncol 2000;18:2226-2233.
61. Movsas B, Scott C, Langer C et al. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol 2005;23:2145-2154.
62. Malik R, Mell LK, Mundt AJ. The effect of amifostine on response rates in advanced non-small cell lung cancer patients treated on randomized controlled trials: a meta-analysis. Proc Am Soc Therap Radiat Oncol 2005; in press.
63. Gauden SJ, Tripcony L. The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population. Lung Cancer 2001;32:71-79.
64. Furuta M, Hayakawa K, Katano S et al. Radiation therapy for stage I-II non-small cell lung cancer in patients aged 75 years and older. Jpn J Clin Oncol 1996;26:95-98.
65. Dosoretz DE, Katin MJ, Blitzer PH et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 1992;24:3-9.
66. Sibley GS, Jamieson TA, Marks LB et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 1998;40:149-154.
67. Krol AD, Aussems P, Noordijk EM et al. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 1996;34:297-302.
68. Graham MV, Purdy JA, Emami B et al. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 1995;33:993-1000.
69. Sandler HM, Curran WJ, Turrisi AT. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1990;19:9-13.
70. Kaskowitz L, Graham MV, Emami B et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993;27:517-523.
71. Blomgren H, Lax I, Naslund I et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-870.
72. Timmerman R, Papiez L, McGarry R et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-1955.
73. Onishi H, Araki T, Shirato H et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623-1631.
74. Schild SE, Stella PJ, Brooks BJ et al. Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer 2005;103:2349-2354.
75. Quon H, Shepherd FA, Payne DG et al. The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 1999;43:39-45.
76. Jeremic B, Shibamoto Y, Acimovic L et al. Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a phase II study. Cancer 1998;82:836-841.
77. Busch E, Kemeny M, Fremgen A et al. Patterns of breast cancer care in the elderly. Cancer 1996;78:101-111.
78. Du X, Freeman JL, Freeman DH et al. Temporal and regional variation in the use of breast-conserving surgery and radiotherapy for older women with early-stage breast cancer from 1983 to 1995. J Gerontol 1999;54:M474-M478.
79. Steinfeld AD, Diamond JJ, Hanks GE et al. Patient age as a factor in radiotherapy. Data from the Patterns of Care Study. J Am Geriatr Soc 1989;37:335-338.
80. Kantorowitz DA, Poulter CA, Sischy B et al. Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1988;15:263-270.
81. Ballard-Barbash R, Potosky AL, Harlan LC et al. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996;88:716-726.
82. Joslyn SA. Radiation therapy and patient age in the survival from early-stage breast cancer. Int J Radiat Oncol Biol Phys 1999;44:821-826.
83. Mandelblatt JS, Kerner JF, Hadley J et al. Variations in breast carcinoma treatment in older medicare beneficiaries: is it black or white. Cancer 2002;95:1401-1414.
84. Veronesi U, Marubini E, Mariani L et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001;12:997-1003.
85. Fisher B, Anderson S, Bryant J et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241.
86. Fyles AW, McCready DR, Manchul LA et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004;351:963-970.
87. Fisher B, Bryant J, Dignam JJ et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002;20:4141-4149.
88. Truong PT, Lee J, Kader HA et al. Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy. Eur J Cancer 2005;41:1267-1277.
89. Ugnat AM, Xie L, Morriss J et al. Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. Br J Cancer 2004;90:1138-1143.
90. Vlastos G, Mirza NQ, Meric F et al. Breast conservation therapy as a treatment option for the elderly. The M. D. Anderson experience. Cancer 2001;92:1092-1100.
91. Toonkel LM, Fix I, Jacobson LH et al. Management of elderly patients with primary breast cancer. Int J Radiat Oncol Biol Phys 1988;14:677-681.
92. Peschel RE, Wilson L, Haffty B et al. The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III-IV gliomas. Int J Radiat Oncol Biol Phys 1993;26:539-544.
93. Hughes KS, Schnaper LA, Berry D et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971-977.
94. Gold HT, Dick AW. Variations in treatment for ductal carcinoma in situ in elderly women. Med Care 2004;42:267-275.
95. Vicini FA, Recht A. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature. J Clin Oncol 2002;20:2736-2744.
96. Van Zee KJ, Liberman L, Samli B et al. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age. Cancer 1999;86:1757-1767.
97. Silverstein MJ, Buchanan C. Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status. Breast 2003;12:457-471.
98. Sleeves RA, Phromratanapongse P, Wolberg WH et al. Cosmesis and local control after irradiation in women treated conservatively for breast cancer. Arch Surg 1989;124:1369-1373.
99. Pezner RD, Patterson MP, Lipsett JA et al. Factors affecting cosmetic outcome in breast-conserving cancer treatment-objective quantitative assessment. Breast Cancer Res Treat 1992;20:85-92.
100. Turesson I, Nyman J, Holmberg E et al. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996;36:1065-1075.
101. Wyckoff J, Greenberg H, Sanderson R et al. Breast irradiation in the older woman: a toxicity study. J Am Geriatr Soc 1994;42:150-152.
102. Overgaard M, Jensen MB, Overgaard J et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641-1648.
103. Bentzen SM, Overgaard M, Thames HD. Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys 1989;17:531-537.
104. Olsen NK, Pfeiffer P, Johannsen L et al. Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys 1993;26:43-49.
105. Erickson VS, Pearson ML, Ganz PA et al. Arm edema in breast cancer patients. J Natl Cancer Inst 2001;93:96-111.
106. Pezner RD, Patterson MP, Hill LR et al. Arm lymphedema in patients treated conservatively for breast cancer: relationship to patient age and axillary node dissection technique. Int J Radiat Oncol Biol Phys 1986;12:2079-2083.
107. Louis-Sylvestre C, Clough K, Asselain B et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 2004;22:37-101.
108. Hanks GE, Hanlon A, Owen JB et al. Patterns of radiation treatment of elderly patients with prostate cancer. Cancer 1994;74:2174-2177.
109. Huguenin PU, Bitterli M, Lutolf UM et al. Localized prostate cancer in elderly patients. Outcome after radiation therapy compared to matched younger patients. Strahlenther Onkol 1999;175:554-558.
110. Johnstone PA, Riffenburgh RH, Moul JW et al. Effect of age on biochemical disease-free outcome in patients with T1-3 prostate cancer treated with definitive radiotherapy in equal-access health care system. Int J Radiat Oncol Biol Phys 2003;55:964-969.
111. Villa S, Bedini N, Fallai C et al. External beam radiotherapy in elderly patients with clinically localized prostate adenocarcinoma: age is not a problem. Crit Rev Oncol Hematol 2003;48:215-225.
112. D'Amico AV, Cote K, Loffredo M et al. Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma. Cancer 2003;97:56-62.
113. Jani AB, Parikh SD, Vijayakumar S et al. Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer. Urology 2005;65:1157-1162.
114. Liu L, Glicksman AS, Coachman N et al. Low acute gastrointestinal and genitourinary toxicities in whole pelvis irradiation of prostate cancer. Int J Radiat Oncol Biol Phys 1997;38:65-71.
115. Steinberg GD, Bales GT, Brendler CB. An analysis of watchful waiting for clinically localized prostate cancer. J Urol 1998;159:1431-1436.
116. Bill-Axelson A, Holmberg L, Ruutu M et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005;352:1977-1984.
117. Neulander EZ, Duncan RC, Tiguert R et al. Deferred treatment of localized prostate cancer in the elderly: the impact of the age and stage at the time of diagnosis on the treatment decision. BJU Int 2000;85:699-704.
118. Xing L, Wu Q, Yang Y et al. The physics of IMRT. In: Mundt AJ, Roeske JC, eds. Intensity Modulated Radiation Therapy: A Clinical Perspective. Hamilton, Ontario: BC Decker; 2005:20-52.
119. Mell LK, Mehrotra A, Mundt AJ. Intensity modulated radiation therapy in the United States, 2004. Cancer 2005; in press.
120. Lee N, Xia P, Fischbein NJ et al. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 2003;57:49-60.
121. Chao KSC, Deasy JO, Markman J et al. A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity-modulated or 3-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;49:907-916.
122. Zelefsky MJ, Fuks Z, Happersett L et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000;55:139-140.
123. Zelefsky MJ, Fuks Z, Hunt M et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002;53:1111-1116.
124. Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003;56:1354-1360.
125. DeWyngaert J, Lymberis SC, MacDonald S et al. Accelerated IMRT with concomitant boost after breast-conserving therapy (BCT): preliminary clinical results and dose volume (DVH) analysis. Int J Radiat Oncol Biol Phys 2004;60:493-504.
126. Kupelian PA, Reddy CA, Carlson TP et al. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2002;53:904-912.
127. Djemil T, Reddy CA, Willoughby TR et al. Hypofractionated intensity-modulated radiation therapy (70 Gy at 25 Gy per fraction) for localized prostate cancer [abstract]. Int J Radiat Oncol Biol Phys 2003;57:S275-S276.
128. Milker-Zabel S, Zabel A, Thilmann C et al. Clinical results of re-treatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2003;55:315-324.
129. Pollock BE. Stereotactic radiosurgery for intracranial meningiomas: indications and results. Neurosurg Focus 2003;14:4-8.
130. Schomas DA, Roeske JC, Macdonald RL et al. Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol 2005;28:180-187.
131. Selek U, Chang EL, Hassenbusch SJ et al. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys 2004;59:1097-1106.
132. Shehata MK, Young B, Reid B et al. Stereotactic radiosurgery of 468 brain metastases ≤ 2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 2004;59:87-93.
133. De Salles AA, Pedroso AG, Medin P et al. Spinal lesions treated with Novalis shaped beam intensity-modulated radiosurgery and stereotactic radiotherapy. J Neurosurg 2004;101:435-440.
134. Martinez A, Gonzalez J, Spencer W et al. Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. J Urol 2003;169:974-979.
135. Potters L, Morgenstern C, Calugaru E et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 2005;173:1562-1566.
136. Sharkey J, Cantor A, Sole Z et al. 103Pd brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer: a 12-year experience from a single group practice. Brachytherapy 2005;4:34-44.
137. Merrick GS, Butler WM, Wallner KE et al. The impact of radiation dose to the urethra on brachytherapy-related dysuria. Brachytheraphy 2005;4:45-50.
138. Merrick GS, Butler WM, Wallner KE et al. Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA < 20 ng/ml. Am J Clin Oncol 2004;27:611-615.
139. Stolier AJ, Fuhrman GM, Scroggins TG et al. Post-lumpectomy insertion of the Mammosite brachytherapy device using the scar entry technique: initial experience and technical considerations. Breast J 2005;11:199-203.
140. Dowlatshahi K, Snider HC, Gittleman MA et al. Early experience with balloon brachytherapy for breast cancer. Arch Surg 2004;139:603-607.